The production of currently available vectors derived from autonomous parvoviruses requires the expression of capsid proteins in trans, from helper sequences. Cotransfection of a helper plasmid always generates significant amounts of replication -competent virus ( RCV ) that can be reduced by the integration of helper sequences into a packaging cell line. Although stocks of minute virus of mice ( MVM ) -based vectors with no detectable RCV could be produced by transfection into packaging cells; the latter appear after one or two rounds of replication, precluding further amplification of the vector stock. Indeed, once RCVs become detectable, they are efficiently amplified and rapidly take over the culture. Theoretically RCV -free vector stocks could be produced if all homology between vector and helper DNA is eliminated, thus preventing homologous recombination. We constructed new vectors based on the structure of spontaneously occurring defective particles of MVM. Based on published observations related to the size of vectors and the sequence of the viral origin of replication, these vectors were modified by the insertion of foreign DNA sequences downstream of the transgene and by the introduction of a consensus NS -1 nick site near the origin of replication to optimize their production. In one of the vectors the inserted fragment of mouse genomic DNA had a synergistic effect with the modified origin of replication in increasing vector production.
T he genome of parvovirus minute virus of mice prototype strain [MVM( p )] is well characterized; it has been cloned and entirely sequenced. 1, 2 Nevertheless, some aspects of the regulation of its gene expression and of particle production are still not well understood. The 5 -kb singlestranded, linear genome of MVM( p) encodes two sets of proteins from overlapping genes. The nonstructural proteins, NS -1 and NS -2, are expressed under control of the P4 promoter. NS -1 is a pleotropic, mainly nuclear phosphoprotein. 3 It mediates the toxicity of MVM in transformed cells 4, 5 and is involved in viral DNA replication and promoter regulation. 6 -8 NS -1 transactivates, for instance, the promoter of capsid proteins, VP -1 and VP -2.
9, 10 The different functions of NS -1 are modulated by differential phosphorylation in the course of the viral infectious cycle. 11, 12 Replication of H -1 and MVM has been shown to take place in nuclear structures called PAR bodies (H -1 ) or APAR bodies (MVM) (autonomous parvovirus -associated replication bodies ) that are formed after infection. 13, 14 Two adjacent elements, A and B, have been identified at the right side of the genome as being necessary in cis for efficient replication. These internal replication sequences ( IRS ) partially overlap the 3 0 extremity of capsid genes. They bind as yet nonidentified cellular protein complexes called MVM replication factors ( MRF ). 15 A 65 -nucleotide tandemly repeated sequence further downstream has also been reported to be involved in a positive modulation of replication. 16 However, data obtained from the study of spontaneously occurring defective particles indicate that particles as small as 15% the size of wild -type MVM( p) are able to replicate. 17 These defective particles always retain the two terminal palindromes of 115 and 206 nucleotides that contain the 3 0 and 5 0 origins of replication, respectively. The minimal elements of these origins have been defined; both contain an NS -1 nick site. In the 3 0 ori, a parvovirus initiation factor (PIF = cellular cofactor ) and an NS -1 binding site have been identified. 18 In the 5 0 ori, two NS -1 binding sites are required to create a functional origin in the presence of the cellular factor HMG1. 19 The smallest defective particles we have isolated have retained all these elements, but have lost part or all of the IRS. 20 Vectors were derived from two types of defective particles, pVD7 and pVD4. The first has lost all capsid -coding sequences and most of the IRS element A, the second retains the complete IRS and 161 terminal nucleotides of the VP coding sequence. These second -generation vectors were constructed as an attempt to eliminate recombination between vector and helper sequences, and to allow for the production of recMVM stocks devoid of replication -competent virus ( RCV ). Two second -generation helpers were also designed that have reduced homology with the vectors upstream of the transgene and that have no homology with the smallest vector downstream of the transgene. It was recently reported that eliminating all homology between vector and helper sequences upstream of the transgene greatly reduced the generation of RCV without eliminating it. 21 Our second -generation vectors replicated as efficiently as first -generation vectors but they produced 10-to 50-fold less concentrated stocks after cotransfection with helper plasmids. 20 This low yield is probably due in part to their small size. Indeed, vectors with a size below 92% that of wild -type MVM (wtMVM ) are produced inefficiently, but the structure of the genome also influences particle yield. 20, 22 In these vectors, the limiting step seems to be packaging rather than DNA amplification. To increase the production of pVD7 -and pVD4 -derived vectors, we therefore modified their size and structure by adding foreign DNA sequences, from bacteriophage l or from mouse genomic DNA, into a noncoding region between the transgene and the right -hand palindrome. Furthermore, a complete origin of viral replication was restored by the addition of an NS -1 nicking site at the vector / plasmid junction. 23 Whereas each of these modifications only slightly increased vector production, combining the two allowed generation of a vector with titers comparable to those of first -generation vectors, but with no detectable RCV after cotransfection with a matched helper plasmid.
Materials and methods

Cell lines
NBE and NBK human fibroblasts were used for transfection and infection, respectively. 22 All cells were grown in DMEM (Invitrogen, Paisley, Scotland, UK ) with 10% fetal calf serum ( PAA Laboratories , Linz, Austria).
Plasmids
Vectors and helper plasmids are described in Figure 1 . MVM( p ) coordinates are given according to Astell et al. 2 Vectors. The first -generation vector pULB3282 and secondgeneration vectors derived from pVD4 or pVD7 have been described. 20 pVD4 -derived vectors, pULB3377 and pULB3379, retain the terminal 161 bp of capsid coding sequences whereas pVD7 -derived vectors, pULB3373 and pULB3375, have lost all such sequences. pULB3377 and pULB3373 differ from pULB3379 and pULB3375 by the site of insertion of the IL -2 cDNA, PflMI( 2588 ) or HindIII( 2650), respectively (Fig 1) .
Insertion of phage l sequences. Blunt -ended fragments of phage l DNA, PvuII ( 20695 ) -PstI ( 22421 ) or HincII ( 21902 ) -HindIII ( 23130 ) , were inserted in the StuI site of pUC -IL -2 behind the IL -2 cDNA 24 to give plasmids pULB3365 or pULB3367, respectively. In plasmid pULB3366 the phage l sequence of pULB3365 was partially deleted (fragment EcoRV ( 21269 ) -SacII ( 21606 ) ). The IL-2/ l fragments from pULB3366 (1389 bp of l DNA ) and pULB3367 (1228 bp of l DNA ) were cloned into the different vectors. Plasmids pUL3378 and pULB3380 are derived from pVD4 and contain the IL -2 /l fragment from pULB3367 inserted into the PflMI and HindIII site of MVM, respectively. Plasmids pULB3374 and pULB3376 are derived from pVD7 by insertion of the IL -2/ l fragment from pULB3366 in the same sites.
The 645 -bp phage l sequence 22 BamHI ( 22346 ) -PvuII ( 22991 ) was cloned into pULB3375 in the same StuI site, in sense and antisense orientation to generate plasmids pULB3385 and pULB3386, respectively.
Plasmid pULB3387 is derived from pULB3386 by the substitution of the HincII -HindIII fragment for the BamHIPvuII fragment of l.
Insertion of random sequences of mouse genomic DNA. Ten micrograms of mouse genomic DNA were digested with XbaI (50 U ), BamHI, and EcoRI (100 U each) or XbaI, EcoRV, and StuI ( 50 U each), followed by blunt -ending with Klenow enzyme. The digestion mixture was separated by gel electrophoresis, fragments of 800-1400 bp were recovered and purified by QiaexII ( Qiagen, Hilden, Germany ). The pool of fragments was then ligated into the StuI site behind the IL -2 coding sequence in pULB3375 to generate clones pGENx, where x is the size of the vector genome expressed as % of wtMVM. Mouse DNA inserts 
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Parvoviral vectors derived from defective particles N Clément et al were partially sequenced using a probe that hybridizes to the end of the IL -2 cDNA.
All vectors with phage l or mouse genomic DNA inserts were obtained through subcloning steps, the details of which can be obtained upon request. The XbaI site belonging to the pUC backbone of plasmids pULB3385 and pULB3386 as well as of all pGEN clones has been removed as a result of one of these steps.
Vectors with restored origin. Two complementary oligomers were synthesized and annealed as follows (the sequence that was added to restore the replication origin is underlined )
This se-quence was then inserted into plasmid pULB3375 between the unique restriction sites KpnI and Bsa AI ( MVM, 26 ) to yield plasmid pORI3375. Its presence was checked by Southern blot analysis of restricted DNA with a 5 0 -32 P -labeled primer ( 5 0 -TGATAAGCGGTTCAGGGAG TTT-3 0 ). The pORIGEN90 vector was obtained by insertion of the EcoRI ( pUC -18 ) -EcoRI ( MVM, 1081 ) fragment from pORI3375 into the corresponding sites of a pGEN vector with 90% the size of wtMVM, pGEN90.
All vector plasmids were amplified in the DL795 bacterial strain to avoid deletions in the 5 0 palindrome. 25 Helper plasmids. The second -generation helpers, pP38 -VP and pPSV40 -VP, have been described. 20 They share no homology with second -generation vectors to the right of the transgene.
Transfections
Transfections were performed by the calcium phosphate coprecipitation method as previously described. 24 
Vector production
Cells seeded the previous day (1.3Â10 5 cells/6 cm dish ) were transfected with 3 g of vector plasmid and a 3 -fold molar excess of helper plasmid. Stocks were produced as total lysates, i.e., cells were lysed in their culture medium, 5 ml /6 cm dish, by three cycles of freeze thawing at À 808C/ 378C. This production method partially explains the relatively low titers of vectors compared to other published work. Other authors discard the culture supernatant and lyse cells in one -tenth of the volume, which is equivalent to a 10-fold concentration. 21, 23 Replication Replication of MVM-derived vectors was monitored by Southern blot analysis of Hirt's extracts prepared 2 days after transfection with 1 g of each vector plasmid. 22 A 32 Plabeled NS1 ( NcoI, 259 -1897 ) probe was used.
Infections
Cells (2.5Â10
5 cells / 6 cm dish ) were infected with 0.5 ml of total lysate of transfected or infected cells as previously published. 24 IL -2 production IL -2 production was measured by ELISA, in culture supernatants, 3 days after transfection or infection. 22 
Results
Addition of phage l DNA Second -generation vectors based on the genome of two cloned defective particles, pVD4 and pVD7, retain only the 756 and 582 terminal nucleotides, respectively, of MVM. They were generated by inserting the IL-2 cDNA into the PflMI ( 2588 ) or HindIII ( 2650 ) site of MVM, generating vectors pULB3377 or pULB3379 with sizes of 76% or 77% ( pVD4 ), and pULB3373 or pULB3375 with sizes of 73% or 74% (pVD7 ) that of wtMVM ( Fig 1 ) . Based on previous results from our group, we attributed the low yield of stocks produced with these vectors, at least in part, to their small size. 22 Therefore, two different fragments of phage l DNA of 1228 and 1389 bp were inserted behind the IL -2 STOP codon in pVD4 (pULB3378, 3380 ) and pVD7 ( pULB3374, 3376) vectors, respectively, to restore the wtMVM size, 100% or 101% depending on whether the IL -2 cDNA was inserted into the PflMI (pULB3378, 3374) or HindIII ( pULB3380, 3376 ) restriction site. Insertion of the l-IL-2 cassette into the PflMI site reduces the homology of the vector with the pPSV40 -VP helper, upstream of the transgene, to 319 nucleotides compared with 380 nucleotides for insertion in the HindIII site. The 1228-bp l fragment was also inserted into the pVD7 vector to produce a vector of 98% the size of wtMVM, pULB3387. The insertion of phage l DNA slightly decreased the production of pVD4 -derived vectors, pULB3377 and pULB3379, and reduced the production of pVD7 -derived vectors by two to three orders of magnitude so that it became undetectable for pULB3374 and pULB3376 (Fig 2B ) . These results correlated with reduced or undetectable genome replication for vectors pULB3378 and pULB3380, or pULB3374 and pULB3376, respectively (results not shown ). Transfection of these vectors yielded IL-2 expression, indicating that the P38 -IL -2 expression cassette was functional. This expression was, however, substantially reduced for pULB3374 and pULB3376 (Fig 2A ) . A BamHI -PvuII fragment from phage l, which in the previous study had allowed a 30 -fold increase in vector production, 22 proved inefficient in the pVD7 vector whether it was cloned in sense (pULB3385 ) or antisense ( pULB3386 ) orientation (results not shown ).
As opposed to pVD7 -derived vectors, stocks produced by cotransfection of all pVD4-derived vectors contained large amounts of RCV ( Fig 2C ) . These vectors were, therefore, not further studied.
Addition of mouse genomic DNA
Only the pVD7 -derived pULB3375 vector was further developed. This vector shares no homology with the helper sequences downstream of the transgene and, compared to pULB3373, it yields more concentrated stocks that are also RCV-free. Another set of modifications consisted in the insertion of mouse genomic DNA sequences at the same position behind the IL-2 STOP codon of pULB3375. A pool
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of fragments ranging in size between 800 and 1400 bp were isolated after digestion with XbaI, EcoRV and StuI and inserted into the pULB3375 vector. Plasmid mini preparations of 19 clones with random insertions were transfected into permissive cells. The sizes of the corresponding pGEN vectors ranged between 88% and 102% that of wtMVM. Six of these vectors showed significant transduction efficiency as judged by the IL -2 produced after infection of NBK cells, with pGEN90 being consistently the most efficient ( Fig 3 ) . Efficient replication was only seen for three of them, as measured by the formation of monomeric replication form DNA (mRF ), pGEN88, pGEN90, and pGEN92 ( results not shown ). pGEN90 was further characterized in comparison to its precursor, pULB3375, and to the first -generation vector, pULB3282. IL-2 expression after infection was equivalent for pULB3375 /pPSV40 -VP, pGEN90/pPSV40 -VP, and pGEN90 /pP38 -VP stocks (Fig 4 ) . pULB3282 and pULB3375 were both influenced by the type of helper used for their production; the former gave better IL-2 expression when produced with pP38 -VP, the latter seemed to be somewhat more efficiently produced with pPSV40 -VP. This relation between vectors and helpers was confirmed by the titration of transducing units (Fig 4B ) . The genomic DNA insertion only slightly increased the production of transducing units in the presence of the pP38 -VP helper but had no effect when stocks were produced with the pPSV40 -VP helper.
Restoration of the parvoviral replication origin
It has been recently published that the NS1 cleavage site is missing from the 3 0 replication origin in the molecular clone of MVM( p ) from which all current MVM vectors have been derived. 23 A first strategy to clone the intact origin from dimeric replication forms ( dRFs ), isolated from wtMVMinfected cells, failed. Arguing that this might be due to the small amount of dRF produced during replication, we tried to Cancer Gene Therapy The pORI3375 clone was selected, based on its functionality after transfection and infection. DNA replication of this new vector was at least as efficient as that of pULB3375 ( Fig 5 ) . IL -2 expression from pORI3375 -infected cells was 4 -and 20 -fold higher compared with pULB3282 -and pULB3375 -infected cells when stocks were produced with the pPSV40 -VP helper ( Fig 6A ) . It was lower for both second -generation vectors produced with the pP38 -VP helper compared with pULB3282. The titers of pORI3375 stocks were about 5 -fold higher than those of pULB3375 irrespective of the helper plasmid used to produce the stocks. As with pULB3375, pORI3375 stocks produced with pP38 -VP were less concentrated than those of the first -generation vector. The reverse was true for stocks produced with pPSV40 -VP. pORI3375/pPSV40 -VP and pULB3282 / pP38-VP transfected cells produced stocks of recombinant MVM with equivalent titers (Fig 6B ) .
Combination of ORI + and GEN vectors
The 3 0 palindrome of pORI3375 was substituted for that of the pGEN90 vector containing the mouse genomic DNA insert, in vector pORIGEN90. The production of IL -2 after infection with pORIGEN stocks produced with either helper was at least 10 -fold higher than for all other first -or second -generation stocks, except pORI3375 /pPSV40 -VP ( Fig 7A ) . In the same conditions, the production of transducing units was also greatly improved for pORIGEN compared to its precursors ( Fig 8) . Interestingly, this is the only second -generation vector so far whose production is equivalent to that of the first -generation vector with the pP38-VP helper. The transducing activity of the secondgeneration vectors was compared to that of pULB3282 in another set of experiments where cells were infected at the same multiplicity of infection ( MOI ) for the different vector Cancer Gene Therapy Parvoviral vectors derived from defective particles N Clément et al stocks. pORIGEN90 produced about 6 -fold more IL -2 per transducing unit than the first -generation vector and slightly more than its precursor vectors (Fig 9) .
Production of RCV in first -and second -generation vector stocks
Whereas pULB3282 stocks always contained RCV after cotransfection with the pP38-VP helper and in most cases with pPSV40 -VP, second -generation vectors could be produced without detectable RCV with both helpers. The absence of detectable RCV could be due to the lower concentration of pULB3375, pGEN90, and pORI3375 stocks. However, stocks of equivalent concentrations produced with the pPSV40 -VP helper contained more frequently RCV for the first-generation vector ( 6/ 8 stocks ) than for pULB3375 (1 /10 ) or pGEN90 (0 /7 ). Ten -fold more concentrated stocks (10 4 transducing units / mL) of pORI3375 or pORIGEN90 were found positive for RCV in only 2 of 9 or 1 of 5 cases, respectively ( Fig 10) . Thus, the elimination of all homology between the vector and the helper to the right of the transgene greatly reduced the generation of RCV after cotransfection.
Discussion
The production of recombinant MVM( p ) vectors devoid of RCV is important for biosafety reasons but also if these stocks are to be amplified through serial infections of packaging cells. Indeed, the generation of RCV precludes further amplification because wtMVM has a selective advantage over recMVM, presumably at the level of packaging. 22, 26 RCV is generated through homologous recombination between vector and helper DNAs, which could be avoided by eliminating all homology between the two types of sequences. Due to the overlapping coding regions in the parvoviral genome, complete elimination of homology is not straightforward and we therefore determined the structure of spontaneously occurring defective particles to identify the minimal cis -acting sequences required for the completion of the parvoviral life cycle. 20 Second -generation vectors derived from one of these defective particles, pVD7, have lost most of the IRS that has been reported as being necessary for the replication of the viral genome. 27, 28 Nevertheless, these vectors replicated as well as the first -generation vector at least in human NBE cells. However, the production of recMVM particles was about 10 -fold less efficient for second -generation vector pULB3375. This vector is only 74% the size of wtMVM and could have benefited from the insertion of foreign DNA for its production. Indeed various viruses have been shown to Cancer Gene Therapy Parvoviral vectors derived from defective particles N Clément et al require an optimal size for packaging, 29 -31 among which MVM. 22 Alternatively, the absence of encapsidationpromoting elements could explain poor vector production. Removing fragments 3597-4012 or 3597 -4423 from an H -1 vector (MVM equivalents 3636 -4002 and 3636 -4416 ) reduced vector production 5 -or 10 -fold without influencing DNA replication. 23 The presence of elements with a positive effect on encapsidation in this region was inferred from the observation that its replacement with stuffer DNA decreased vector production, speaking against a mere role of size of the vector. We have shown, however, that the overall structure of the vector seems to influence its production although the size also plays a role. 22 In this work, the insertion of some stuffer DNA sequences decreased vector production and a phage l sequence that improved packaging of the first -generation vector had no effect in pULB3375. Moreover, inserting the 3636-4002 fragment of MVM in two different locations in pORIGEN had no effect on vector production. The fragment was inserted so that its position in the vector was about the same as in wtMVM, 3707 -4120 and 3627 -4040 ( unpublished results ).
Interestingly, the type of helper used in the cotransfection does not influence the production of the pGEN90 vector. In general, the first -generation vector pULB3282 produced better stocks with the pP38 -VP helper whereas secondgeneration vectors derived from pVD4 or pVD7 produced better stocks with the pSV40 -VP vector. As judged from the production of pVD4-derived vectors containing phage l DNA inserts, there might be a relation between the size of the vector (pULB3375 is 74% and pGEN90 is 90% the size of wtMVM) and the influence of the type of helper on recMVM production, the smaller vector having an advantage to be produced with pPSV40 -VP. We can, however, not explain this observation.
Restoring the parvoviral origin of replication in vectors pULB3375 and pGEN90 increased the production of transducing particles by one order of magnitude. Kestler et al 23 observed a 400 -fold increase when the replication origin was restored in the wild -type molecular clone of MVM, but these authors did not compare the production of MVM vectors with a complete or an incomplete origin of replication.
Starting from a second -generation vector that lacks all VP -coding sequences but that is produced 10 times less efficiently than the first-generation vector, we could, through different modifications of the vector, produce stocks with the same titer as the first -generation vector, i.e., 10 4 transducing units/ml. These vectors are more efficiently produced with the pPSV40 -VP helper than the first -generation vector. This feature is interesting because the pPSV40 -VP helper has a reduced homology with the vectors upstream from the transgene compared to the pP38 -VP helper.
Second -generation vectors show an increased expression of the transgene that could be due to either an up-regulation of the P38 promoter or an increased stability of messenger RNA. It is, however, difficult to explain why P38 should be more active in second -generation vectors because the sequences surrounding the promoter are identical in both first -and second -generation vectors. All MVM messenger RNAs are very stable. 32 The regulation of this stability is not well understood but it is thought that cis -acting viral determinants that are located in the 5 0 and 3 0 nontranslated extremities of the messengers are involved. 33 These sequences are also present in both first -and secondgeneration vectors. We can, therefore, not give a satisfactory explanation for the increased expression of the transgene in the latter.
The new vectors present two important advantages, they generate stocks that are in most cases devoid of RCV (4 /5 stocks ) and they express large amounts of the transgene. Integrating the helper sequences in a packaging cell line will further decrease recombination and should allow production of high -titer stocks for in vivo intratumoral infection. In an immunocompetent, syngeneic mouse model we could produce an antitumor effect with the first-generation vector pULB3282 at a low MOI (1 ) at which only 0.1% of tumor cells were transduced (El Bakkouri et al, to be published ). The vector we describe here expresses about 6 -fold more IL -2 per particle than pULB3282 and should therefore be efficient at an even lower MOI, further minimizing any risk of inducing an anti -MVM immune response.
